GLI1 and cancer: We have confirmed the correlation between IL-33 and markers like SerpinA1, SerpinA3, and EphB2 for SCC and Gli1, Gli2, FOXO3A for BCC as it highlights the complex interplay of cytokines, protease inhibitors, and receptor signaling in cancer.